Rapid Multiplex Antimicrobial Resistance Profiling and Bacterial Identification by LAP‐MALDI Mass Spectrometry Biotyping
- 1Department of Chemistry University of Reading Reading Berkshire UK
- 2Royal Berkshire NHS Foundation Trust Reading Berkshire UK
- 3School of Biological Sciences University of Reading Reading Berkshire UK
Abstract
Rapid and accurate characterization of antimicrobial resistance is essential for effective patient treatment and outcomes. Infection‐causing microorganisms often harbour multi‐drug resistance, requiring multiple tests for identification. Here, we present a multiplex functional assay using liquid atmospheric pressure (LAP) matrix‐assisted laser desorption/ionization (MALDI) as next‐generation MALDI biotyping technology, which can accurately determine antibiotic resistance/susceptibility within three hours from <5 µL of bacterial culture, employing a beta‐lactam antibiotic panel. Strains with common resistance genes, including OXA‐48, KPC‐3, and VIM‐1, as well as susceptible isolates, are easily and reliably classified. Concurrent with multi‐drug testing, the same bacterial sample provides species‐identifying lipid and protein profiles (up to 100% classification accuracy) and characterization through tandem mass spectrometry (MS/MS) protein sequencing, facilitated by LAP‐MALDI's ability to generate multiply charged protein ions. Detection of multiple antibiotics, their degradation products and lipids/proteins with high mass accuracy, along with the possibility of protein sequencing, offers new diagnostic possibilities for clinical microbiology and antimicrobial stewardship that are less probability‐based than conventional MALDI biotyping.
Related
- Cross-kingdom antimicrobial resistance profiling: A unified multiplex PCR assay for simultaneous bacterial and fungal detection
- Phenotypic and multiplex PCR-defined antimicrobial resistance in Ukrainian soldiers’ war-wound microbiota
- Genomic analysis and antimicrobial resistance profiling of Klebsiella pneumoniae clinical isolates from urinary tract infections in India: prevalence of class A β-lactamase with molecular docking and simulation insights.
- Pathogen-targeted quick multiplex PCR identification of Chlamydia psittaci and Haemophilus influenzae coinfection in pneumonia: a case report.
- A novel multiplex assay for species-level identification of non-tuberculous mycobacteria in culture-positive respiratory specimens based on capillary electrophoresis: development and clinical validation
BibTeX
@article{adair2026rapid,
title = {{Rapid Multiplex Antimicrobial Resistance Profiling and Bacterial Identification by LAP‐MALDI Mass Spectrometry Biotyping}},
author = {Lily R. Adair and Shabnam Iyer and Ian M. Jones and Rainer Cramer},
journal = {Advanced Science},
year = {2026},
month = jul,
doi = {10.1002/advs.76927},
url = {https://doi.org/10.1002/advs.76927},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Rapid Multiplex Antimicrobial Resistance Profiling and Bacterial Identification by LAP‐MALDI Mass Spectrometry Biotyping
AU - Lily R. Adair
AU - Shabnam Iyer
AU - Ian M. Jones
AU - Rainer Cramer
PY - 2026
DA - 2026/07/31
JO - Advanced Science
DO - 10.1002/advs.76927
UR - https://doi.org/10.1002/advs.76927
AB - Rapid and accurate characterization of antimicrobial resistance is essential for effective patient treatment and outcomes. Infection‐causing microorganisms often harbour multi‐drug resistance, requiring multiple tests for identification. Here, we present a multiplex functional assay using liquid atmospheric pressure (LAP) matrix‐assisted laser desorption/ionization (MALDI) as next‐generation MALDI biotyping technology, which can accurately determine antibiotic resistance/susceptibility within three hours from <5 µL of bacterial culture, employing a beta‐lactam antibiotic panel. Strains with common resistance genes, including OXA‐48, KPC‐3, and VIM‐1, as well as susceptible isolates, are easily and reliably classified. Concurrent with multi‐drug testing, the same bacterial sample provides species‐identifying lipid and protein profiles (up to 100% classification accuracy) and characterization through tandem mass spectrometry (MS/MS) protein sequencing, facilitated by LAP‐MALDI's ability to generate multiply charged protein ions. Detection of multiple antibiotics, their degradation products and lipids/proteins with high mass accuracy, along with the possibility of protein sequencing, offers new diagnostic possibilities for clinical microbiology and antimicrobial stewardship that are less probability‐based than conventional MALDI biotyping.
SN - 2198-3844
ER -